TD ASSET MANAGEMENT INC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$1,856,000
-68.9%
40,064
-83.6%
0.00%
-66.7%
Q1 2019$5,967,000
+186.9%
244,761
+67.7%
0.01%
+125.0%
Q4 2018$2,080,000
+23.9%
145,949
+32.1%
0.00%
+100.0%
Q3 2018$1,679,000
-17.4%
110,449
-8.8%
0.00%
-33.3%
Q2 2018$2,033,000
+3.8%
121,149
+0.9%
0.00%0.0%
Q1 2018$1,959,000
+100.1%
120,049
+57.0%
0.00%
+200.0%
Q4 2017$979,000
-5.2%
76,449
-8.9%
0.00%
-50.0%
Q3 2017$1,033,000
+142.5%
83,949
+65.0%
0.00%
+100.0%
Q2 2017$426,000
-57.6%
50,884
-54.7%
0.00%
-50.0%
Q1 2017$1,005,000
+6.0%
112,368
+4.2%
0.00%0.0%
Q4 2016$948,000
-6.4%
107,868
-51.4%
0.00%0.0%
Q3 2015$1,013,000
-54.8%
222,100
-28.5%
0.00%
-50.0%
Q2 2015$2,241,000
-8.0%
310,800
-5.9%
0.00%0.0%
Q1 2015$2,435,000
+51.5%
330,400
-2.7%
0.00%
+33.3%
Q4 2014$1,607,000
+37.6%
339,700
+3.8%
0.00%
+50.0%
Q3 2014$1,168,000
-24.4%
327,300
-3.3%
0.00%
-33.3%
Q2 2014$1,544,000
-9.3%
338,500
-6.6%
0.00%0.0%
Q1 2014$1,703,000
+1.9%
362,300
+8.6%
0.00%0.0%
Q4 2013$1,671,000
-17.9%
333,500
+1.9%
0.00%
-25.0%
Q3 2013$2,035,000
+100.1%
327,200
+46.0%
0.00%
+100.0%
Q2 2013$1,017,000224,1000.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Redmile Group, LLC 15,978,580$268,121,0009.11%
BVF INC/IL 4,672,195$78,399,0007.65%
First Light Asset Management, LLC 2,391,575$40,131,0006.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 694,500$11,647,0004.47%
Copernicus Capital Management, LLC 286,797$4,812,0003.49%
PACIFIC VIEW ASSET MANAGEMENT, LLC 225,511$3,784,0003.00%
SECTORAL ASSET MANAGEMENT INC 1,566,477$26,285,0002.94%
X-Square Capital, LLC 173,802$2,917,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,618,654$43,941,0001.48%
Birchview Capital, LP 128,000$2,148,0001.46%
View complete list of ARRAY BIOPHARMA INC shareholders